Holen Sie sich die Stockscreener-App
18.37
1.31%
-0.2184
Schlusskurs vom Vortag:
$18.59
Offen:
$18.48
24-Stunden-Volumen:
119.65K
Relative Volume:
0.05
Marktkapitalisierung:
$5.25B
Einnahmen:
$1.19B
Nettoeinkommen (Verlust:
$117.80M
KGV:
44.78
EPS:
0.4103
Netto-Cashflow:
$92.48M
1W Leistung:
-3.23%
1M Leistung:
-2.72%
6M Leistung:
+25.92%
1J Leistung:
+16.04%
1-Tages-Spanne:
$18.29
$18.55
1-Wochen-Bereich:
$18.29
$19.21
52-Wochen-Spanne:
$13.09
$19.85
Sotera Health Co Stock (SHC) Company Profile
Firmenname
Sotera Health Co
Sektor
Branche
Telefon
440-262-1410
Adresse
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, NTRA, IQV, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
18.38 | 5.31B | 1.19B | 117.80M | 92.48M | 0.4103 |
TMO
Thermo Fisher Scientific Inc
|
603.56 | 222.97B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.21 | 144.27B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
324.81 | 46.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
256.66 | 42.67B | 16.63B | 1.39B | 2.12B | 8.0674 |
IDXX
Idexx Laboratories Inc
|
518.88 | 40.98B | 4.45B | 1.10B | 1.06B | 13.59 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-12-18 | Eingeleitet | William Blair | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-05-05 | Hochstufung | Goldman | Neutral → Buy |
| 2024-12-06 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Eingeleitet | Piper Sandler | Neutral |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-03-25 | Hochstufung | Jefferies | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-01-11 | Hochstufung | Barclays | Underweight → Overweight |
| 2023-01-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-09-20 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-03-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-03-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Sotera Health Co Aktie (SHC) Neueste Nachrichten
Piper Sandler reiterates Sotera Health stock rating on growth outlook By Investing.com - Investing.com South Africa
Piper Sandler reiterates Sotera Health stock rating on growth outlook - Investing.com
Sotera Health Co (SHC) Peer Comparison – Compare with Others - Value Research
Insider Selling: Michael Petras Jr Unloads $21.17M Of Sotera Health Stock - Benzinga
Bank of America Corp DE Buys 991,620 Shares of Sotera Health Company $SHC - MarketBeat
Insider Selling: Sotera Health (NASDAQ:SHC) Chairman Sells 850,000 Shares - MarketBeat
Research Tools & Consumables Stocks Q2 Recap: Benchmarking Sotera Health Company (NASDAQ:SHC) - Yahoo Finance
Sotera Health (NASDAQ: SHC) affiliate eyes $21.6M stock sale - Stock Titan
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
State of Wyoming Buys Shares of 56,651 Sotera Health Company $SHC - MarketBeat
Sotera Health president Rutz sells $2.83m in common stock - Investing.com
What Sotera Health (SHC)'s Strong Q2 Beat and Raised Outlook Means For Shareholders - simplywall.st
Sotera Health Company’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Sotera Health (SHC): Sculptor Capital discloses 24M-share, 8.41% ownership stake - Stock Titan
Sotera Health (SHC): Sessa Capital discloses 27M-share, 9.5% ownership position - Stock Titan
Sotera Health announces resignation of director James C. Neary - Investing.com
Sotera Health announces resignation of director James C. Neary By Investing.com - Investing.com Nigeria
Form 8K Sotera Health Co For: 14 August By Investing.com - Investing.com Nigeria
James C. Neary Steps Down from Sotera Health Board, Board Size Now Eleven - Kalkine Media
Loving Living Local: Solvera Health - AOL.com
President of Sterigenics U.S. Of Sotera Health Sold 37% Of Their Shares - simplywall.st
Sotera Health Company (SHC) Stock Forecasts - Yahoo Finance
Insider Transaction: Michael Rutz Sells $2.83M Worth Of Sotera Health Shares - Benzinga
Sotera Health Company (SHC) Stock forecasts - Yahoo Finance UK
Sotera Health (NASDAQ:SHC) Insider Sells $2,826,000.00 in Stock - MarketBeat
Quantinno Capital Management LP Has $2.83 Million Position in Sotera Health Company $SHC - MarketBeat
Sotera Health (SHC) Is Getting Attention Again, What Is Behind It? - simplywall.st
Renaissance Technologies LLC Reduces Holdings in Sotera Health Company $SHC - MarketBeat
SHC Q2 Deep Dive: Broad-Based Growth, Leadership Transition, and Strategic Investments Shape Outlook - Yahoo Finance
Sotera Health (SHC) Stock Trails Profit Surge As Legal Risks Linger - simplywall.st
SHC SWOT Analysis: Strong Revenue Growth Amidst Legal Challenges Revealed in 10-Q Filing - GuruFocus
Sotera Health (NASDAQ:SHC) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
SHC Maintained by Citigroup -- Price Target Raised to $25.00 - GuruFocus
SHC Maintained by Barclays -- Price Target Raised to $22.00 - GuruFocus
SHC Maintained by JP Morgan -- Price Target Raised to $18.00 - GuruFocus
SHC Reiterated by Piper Sandler -- Price Target Raised to $25.00 - GuruFocus
Piper Sandler Reaffirms "Overweight" Rating for Sotera Health (NASDAQ:SHC) - MarketBeat
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Sotera Health (NASDAQ:SHC) Stock - MarketBeat
Charles Schwab Corp (SHC) holder plans sale of 150,000 common shares - Stock Titan
Earnings call transcript: Sotera Health tops Q2 2026 estimates, lifts outlook - Investing.com Nigeria
Sotera Health Co (SHC) Shares Surge 5.1% -- What GF Score of 77 Tells Investors - GuruFocus
Sotera Health Co 2026: Revenue $321.38M, EPS $0.19— 10-Q Summary - tradingview.com
Sotera Health beats Q2 estimates, raises full-year outlook - Investing.com
Is Sotera Health Co (SHC) Overvalued After Q2 Earnings Beat? EPS at $0.19 vs. Est. $0.17; Revenue at $321.4M - GuruFocus
Sotera Health Company (NASDAQ:SHC) Surprises With Strong Q2 CY2026 - Yahoo Finance
Sotera Health beats Q2 estimates, raises full-year outlook By Investing.com - Investing.com Canada
Sotera Health posts Q2 2026 net revenues $321.4M; Q2 adjusted EPS $0.26, raises FY 2026 outlook - TradingView
Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook - Yahoo Finance Singapore
BlackRock, Inc. Adds to Sotera Health Co (SHC) Stake -- Shares S - GuruFocus
Sotera Health earnings loom as investors eye new CEO’s execution By Investing.com - Investing.com Nigeria
Earnings To Watch: Sotera Health Co (SHC) Reports Q2 2026 Result - GuruFocus
Finanzdaten der Sotera Health Co-Aktie (SHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.07%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):